The Erythropoietin (EPO) Drugs Market size is expected to grow at an annual average of 4% during 2022-2028. Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that induces red blood cell production in the bone marrow through red blood cell production. Erythropoietin drugs were developed to treat end-stage renal disease (ESRD) disease and anemia conditions resulting from […]
Tag Archives: Erythropoietin (EPO) Drugs Market
The Erythropoietin (EPO) Drugs Market size is expected to grow at an annual average of 4% during 2021-2027. Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that induces red blood cell production in the bone marrow through red blood cell production. Erythropoietin drugs were developed to treat end-stage renal disease (ESRD) disease and anemia conditions resulting from […]